Newbridge Financial Services Group, Inc. Madrigal Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $224 Million
- Q1 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 11,033 shares of MDGL stock, worth $3 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
11,033Holding current value
$3 Million% of portfolio
1.32%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
315Shares Held
20MCall Options Held
824KPut Options Held
1.04M-
Janus Henderson Group PLC London, X02.6MShares$707 Million0.39% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$535 Million6.66% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.94MShares$528 Million6.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.78MShares$482 Million34.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$453 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.65B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...